GAS5 acts as a competitive endogenous RNA (ceRNA) of miR-21, competitively binding to miR-21 to increase PTEN and promote proliferation and metastasis of trastuzumab-resistant breast cancer cells. The gene discussed is PTEN; the disease is breast carcinoma.